Provided by Tiger Trade Technology Pte. Ltd.

BioNTech SE

102.08
-9.3250-8.37%
Post-market: 102.500.4250+0.42%19:30 EDT
Volume:3.07M
Turnover:314.70M
Market Cap:25.64B
PE:-13.13
High:105.23
Open:102.34
Low:98.80
Close:111.40
52wk High:124.00
52wk Low:79.52
Shares:251.20M
Float Shares:108.00M
Volume Ratio:1.71
T/O Rate:2.85%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.7726
EPS(LYR):-5.5184
ROE:-9.30%
ROA:-5.41%
PB:1.25
PE(LYR):-18.50

Loading ...

BioNTech (BNTX) Could Be 81% Undervalued After New Vaccine Patent Lawsuits

Simply Wall St.
·
Jul 30

BioNTech and Pfizer Secure EU Approval for XFG-Adapted COVID-19 Vaccine for 2026-2027 Season

TIPRANKS
·
Jul 30

Pfizer, BioNTech Updated Covid Vaccine Gets Europe Approval

Dow Jones
·
Jul 30

EU Authorizes Pfizer-BioNTech XFG-adapted COVID Vaccine for Ages 6 Months and Up

Reuters
·
Jul 30

Earning Preview: BioNTech SE Q2 revenue is expected to increase by 6%, institutional views are leaning cautious

Earnings Agent
·
Jul 29

Pfizer (PFE) Faces New Patent Lawsuits Over Covid 19 Vaccine Technology

Simply Wall St.
·
Jul 23

Biontech to Report Q2 2026 Results, Host Investor Call

Reuters
·
Jul 21

Sunrise Names Andreas Tolpeit as New CFO to Drive Profitability and Strategy

TIPRANKS
·
Jul 20

BioNTech (BNTX) Faces Fresh Patent Lawsuits, Is The Valuation Gap Too Wide?

Simply Wall St.
·
Jul 19

How Investors Are Reacting To BioNTech (BNTX) Expanded Global Patent Suits Targeting Its mRNA COVID-19 Vaccines

Simply Wall St.
·
Jul 18

Arbutus Biopharma, Genevant sue Pfizer, BioNTech Over Lipid Nanoparticle Patents

MT Newswires Live
·
Jul 16

Arbutus Files Patent Infringement Suits Against Pfizer, Biontech over LNP Technology

Reuters
·
Jul 16

Arbutus Biopharma Corp - Co and Genevant File Lawsuit in Canada Seeking Injunction and Damages Against Pfizer/biontech

THOMSON REUTERS
·
Jul 16

Analysts Offer Insights on Healthcare Companies: Pro Medicus Limited (OtherPMCUF) and BioNTech SE (BNTX)

TIPRANKS
·
Jul 13

Warburg Research Keeps Their Buy Rating on HYPOPORT (0JVS)

TIPRANKS
·
Jul 09

Cathie Wood Buys More SpaceX, Sells AMD, BioNTech, and Other Growth Stocks, 7/9/26

TIPRANKS
·
Jul 09

Biontech is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Jul 09

Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says

MT Newswires Live
·
Jul 08

Morgan Stanley Adjusts Price Target BioNTech to $119 From $126, Maintains Overweight Rating

MT Newswires Live
·
Jul 08

Essity Names Andreas Mattsson Chief Legal Officer as Veteran Counsel Retires

TIPRANKS
·
Jul 07